The right hand not knowing what the left hand’s doing. Robbing Peter to pay Paul. Talking out of both sides of the mouth. . . . They’re all clichés that aptly describe how the U.S. Congress too often works. Especially…

Inundated with heart-wrenching stories about constituents who can’t afford the prescription drugs they need to live, U.S. lawmakers spend a lot of time lamenting a free market that isn’t working and then debating ways to “fix” it. Reality check: A…

June 1, 2017 – 3:13 pm | By Marie Powers | Comments are off for this post

BioWorld’s inaugural Summer Reading List in 2007 appeared as a simple list of 15 books – including Harry Potter and the Deathly Hallows, harkening to the tone of the times – designed as something a breather from post-ASCO, pre-BIO mania….

LONDON – It was great to be one of the thousands around the world who took to the streets on Saturday to March for Science. In London, people of all ages gathered outside the Science Museum, in high spirits, but…

Hoping to debunk biopharma’s biggest justification for high drug prices, Public Citizen released a report Monday showing that the 20 biggest drug companies collectively generated more than $100 billion in annual profits from 2013 through 2015, nearly double what a…

After a bruising U.S. presidential campaign and, let’s just say, less than conventional preparation for the nation’s 45th president, we could all use a bit of holiday cheer. In a neighborly gesture, Peter Winter, Ottawa-based editor of BioWorld Insight, suggested…

For decades the biotech industry has been hounded by activists over animal testing. Most notably, a campaign against Huntington Life Sciences in the late 1990s through 2000s included arson, harassment, threats and alleged fire bombings. Less severe, but still troubling…